NEW YORK (GenomeWeb News) – Thermo Fisher Scientific late on Thursday priced its offering of $800 million of senior notes at 99.991 percent of the principal amount.

The issuance of the notes is expected to close on or about Nov. 14, the company said. Net proceeds will be used primarily to repay debt, including the $400 million principal amount of its 3.25 percent senior notes due 2014 that mature on Nov. 20.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.